Body weight loss is a simple and useful indicator of prognosis and predictive tolerability in the first year of nintedanib therapy in patients with interstitial lung disease
Article in Respiratory Investigation (April 2024)
The most recent citing publications are shown below. View all 59 publications that cite this research output on Dimensions.
Article in Respiratory Investigation (April 2024)
Article in PLOS Digital Health (January 2024)
Article in Chronic Respiratory Disease (January 2024)